ENTITY
GlaxoSmithKline PLC

GlaxoSmithKline PLC (GSK LN)

108
Analysis
Health CareUnited Kingdom
GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
more
bullishS&P 500 INDEX
14 Nov 2017 20:39

U.S. Equity Strategy & Individual Sector Commentaries

In our November Macro Vision report, we provide an appraisal and recommendations for each of our 12 Sectors, with extra attention devoted...

Logo
326 Views
Share
08 Nov 2017 20:24

Genomics as an Investment Theme

Genomics as an investment theme Costs of sequencing a human genome have fallen to less than $1,000 China leads the world in gene sequencing The...

Logo
314 Views
Share
15 Jun 2017 12:02

Eris Lifesciences: Ask Some Questions, Take the Deal

Eris Lifesciences Limited (0113824Z IN) is an India-focused pharmaceutical company that produces and markets branded generic drugs. The company...

Share
bearishNestle SA
03 Mar 2017 08:36

Brexit and Its Impact on the Largest FMCG Companies

As the UK is set to leave the EU, we can examine the potential impact of Brexit on retail sales of FMCG companies covered in Passport. The exact...

Share
27 Feb 2017 14:28

AI & Machine Learning Disrupting The Healthcare Industry

In the omnipresence of machine learning, one of the most impacted segments is healthcare. Not only is AI in healthcare at the forefront of a...

Logo
601 Views
Share
x